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Long-term pretreatment of rat mesangial cells with 12-0-tetradecanoylphorbol 13”acetate (TPA) down-regulated protein kinase C activity and po- 
tentiated the angiotensin II-induced inositol trisphosphate (InsP,) formation. This increased response to angiotensin II occurred without a signif- 
icant change in the receptor number or & value of angiotensin II binding to the cells. The biologically inactive phorbol ester 4a-phorbol 12,13-d& 
decanoate was without effect on angiotensin II-stimulated InsP, generation. Long-term pretreatment with TPA also increased the angiotensin II- 
induced mobilization of Ca*+ and the subsequent contraction of mesangial cells. 
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I. INTRODUCTION 
Mesangial cells are a major determinant in the regula- 
tion of the glomerular filtration rate [l]. Morpho- 
logically, mesangial cells resemble vascular smooth 
muscle cells and are able to contract upon stimulation 
by vasoactive hormones like angiotensin II [2-41. 
However, the hormone fails to produce a sustained con- 
traction of the cells, reflecting a specific, homologous 
desensitization phenomenon [3-51. The direct action of 
angiotensin II on mesangial cells results in a rapid for- 
mation of inositol 1,4,5-trisphosphate (InsP3) and 
diacylglycerol (DG), which are concomitantly generated 
by the hydrolysis of phosphatidylinositol 4,5bisphos- 
phate [6-B]. InsP3 mobilizes Ca’ + from endoplasmic 
reticulum, while DG activates protein kinase C 19, lo], 
These biochemical signals then interact to cause con- 
traction of mesangial cells [7,8]. Angiotensin II-, 
vasopressin- and ATP-induced generation of InsP3 and 
subsequent Ca2’ mobilization have been shown to be 
decreased or abolished by short-term preincubation 
with 12-0-tetradecanoylphorbol 13-acetate (TPA) 
[ 1 1 - 131. Two further approaches can be chosen in order 
to eiucidate the contribution of protein kinase C to the 
feedback inhibition of angiotensin II-induced phos- 
phoinositide hydrolysis. One approach is the use of in- 
hibitors of protein kinase C, which is limited, however, 
by the partial selectivity of drugs [5]. Alternatively, 
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long-term exposure of mesangial cells to TPA results in 
a down-regulation of protein kinase C [6]. In this report 
we show that down-regulation of protein kinase C 
results in elevated basal and angiotensin II-stimulated 
levels of InsP3, and subsequent amplified Ca2+ mobi- 
lization and contraction of mesangial cells. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Angiotensin II, TPA and 4cY-phorbol l&13-didecanoate were pur- 
chased from Sigma, St. Louis, MO; angiotensin II was also obtained 
from Bachem, Bubendorf, Switzerland; myo-[2-3H]inositol was pur- 
chased from Amersham International, U.K.; [tyrosyl-‘a’I]angiotensin 
II from Anawa, Wangen, Switzerland; flue-3/AM from Molecular 
Probes, Eugene, OR; ionomycin was from Calbiochem, Lucerne, 
Switzerland; all cell culture nutrients were from Boehringer Mann- 
heim, FRG; all other chemicals used were from Merck, Darmstadt, 
FRG. 
2.2. Cell culture 
Rat mesangial cells were cuhivated as described previously 1141. 
The cells were grown in RPM1 1640 supplemented with 2Oqo fetal calf 
serum, penicillin (100 units/ml), streptomycin (iOtl~g/ml) and bovine 
insulin at 0.66 unit/ml (Sigma). Mesangial cells were characterized 
morphologically by phase contrast microscopy, positive staining for 
the intermediate filaments desmin and vimentin, which is considered 
to be specific for myogenic ells [15], negative staining for factor VIII 
related antigen and cytokeratin, excluding endothelial and epithelial 
contamination, respectively. 
2.3. Cell IabeNing 
Confluent mesangial cells in 35 mm diameter dishes were labelled 
for 72 h with myo-[2-3H]inositol ( O&i/ml) in RPM1 1640 free of in- 
ositol, containing 2% dialyzed fetal calf serum. Phorboi esters or 
vehicle were added for the last 24 h of the labelling period. 
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2.4. Extraction and determination of inusitol phosphates 
After the labelling period, the medium was removed and the cells 
were rinsed several times to remove free [3H]inositol and incubated 
for an additional 1 h in fresh medium. After this procedure mesangial 
cells were incubated in 1 ml RPM1 1640 with or without angiotensin 
II for the indicated time periods. Thereafter the reaction was termined 
by rapid aspiration of the medium and addition of 1 ml of 15% (w/v) 
trichloroacetic acid. For extraction of inositol phosphates the dishes 
were put on ice for 1 h. The trichloroacetic acid was then removed 
with diethyl ether. The final extract was neutralized and applied to 
anion exchange columns containing 1 mi of Dowex 1-X8 (100-200 
mesh, formate form; Serva, Heidelberg, FRG). Free inositol and the 
inositol phosphates were eluted sequentiaIIy according to Berridge 
1161 as described [17]. In some experiments inositol phosphates were 
separated by anion exchange HPLC on a Partisil 10 SAX column 
(Whatman, UK) with an ammonium formate gradient (O-l.7 M) [18]. 
The peaks of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 were identified with the 
elution profile of pure standards obtained from Amersham Interna- 
tional, UK. The nature of Ins(l,3,4)Ps was presumed on the basis of 
its coelution with ATP [19]. A 24 h pretreatment of the cells with TPA 
reduced the total water-soluble [3H]inositol content of the cells. Since 
water soluble ]‘H]inositol and its phosphorylated metabolites were 
coprocessed in the separation assay, and thus should be subjected to 
the same losses, the ratios of the phosphorylated compounds relative 
to total water-soluble [3H]inositol were calculated for each sample. 
2.5. A~giotensin II binding assay 
Approx. 10’ cells (approx. 20 mg membrane protein) were suspend- 
ed in 3-5 ml phosphate buffered saline (PBS) and stored at - 70°C. 
The frozen cells were thawed, homogenised in 20 mM NaHCO3 and 
centrifuged at 30000 x g for 20 min. The pellet was suspended in 50 
mM Tris/HCl, pH 7.4 as described [20]. Briefly, aliquots of 2OOpl(lO 
ag protein) were incubated for 60 min at 2SaC with ‘2sI-angiotensin 
II in the presence or absence of cold ligand (0.1-5.0 nM). Nonspecific 
binding was determined in the presence of 1 PM cold angiotensin II. 
The incubation was then terminated by adding ice-cold PBS buffer 
and filtering through Whatman GF/F filters, washing twice. The 
filters were counted in a gamma-counter. The concentration of 
binding sites (Bmax) and equilibrium dissociation constant (Kd) were 
determined as described 1201. 
2.6. measurement Of (CcZ’]i 
(Ca2”]i was measured by using the fluorescent calcium indicator 
flue-3. About 2 x 10’ cells were incubated at 37°C with IS FM 
fluo-J/AM in RPM1 1640 for 30 min. After the incubation period, 
aliquots of 1 x lo6 cells were washed twice and resuspended inHepes- 
buffered saline containing 1.3 mM Ca’+. After additional 30 min at 
37°C the cells were washed again and the angiotensin II-induced 
fluorescence changes of fluo-3-loaded cells were measured by using a 
Perkin-Elmer MPF-66 spectrofluorophotometer. The excitation 
wavelength was fixed at 508 nm (f 5 nm) and the emission 
wavelength at 535 nm (k 7 nm). The fluorescence signals were 
calibrated at the end of each individual scan essentially as described 
by Tsien et al. 1211. A modified Bateman function was used to fit an 
appropriate limination constant o the experimental data. The model 
takes into account an exponenti~ behaviour as follows: 
Intensity z L)1(2-"'e1 - 2-"*n') + &(1-2-"qn2) 
D1;L)2 = maximal responses of first and second calcium channel 
(relative intensity units) 
ret = fluorescence half-life elimination constant 
t = time after angiotensin II addition 
rinl; rinz = fluorescence half-life rise times of first and second 
calcium channel 
The model is based on the idea that two mechanisms are responsible 
for the release and reuptake of Ca *+. The first process (first bracket) 
characterizes the InsPs-induced release of Ca2+ (first calcium chan- 
nel). The second Ca*’ channel (second bracket) corresponds to an in- 
crease of (Ca2’)i by opening calcium channels located in the plasma 
membrane. Further details will be shown elsewhere (M. Ochsner and 
J. Pfeilschifter, manuscript in prep~ation). 
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2.7. Contraction studies 
All contraction studies were performed after a single passage of the 
same primary culture. Cells received fresh medium containing the in- 
dicated concentrations of TPA or vehicle 24 h before the experiment. 
At the start of the experiments mesangial cells were washed twice and 
then incubated with Hanks’ balanced salt solution at 37°C. Phase 
micrographs of 3-5 cells were taken before (0 min) and at 3 and 5 min 
after the addition of angiotensin II (10 nM) as described [4]. 
Measurements of cell surface area were carried out using a Kontron 
digitizer tablet. A decrease in cell surface area of more than 12% was 
considered a contraction. 
3. RESULTS 
Stimulation of mesengial cells by angiotensin II 
(100 nM) caused a rapid increase of Ins(1,4,5)Ps and 
Ins(1,3,4,5)P4 values as shown in fig.1. The 
Ins(1,3,4)P3 isomer showed a somewhat delayed in- 
crease. We have previously shown that a 24 h pretreat- 
ment of mesangial cells with 500 nM TPA diminished 
soluble and particulate protein kinase C activity to 
values below 10% of that of control cells. Protein 
kinase C down-regulated mesangial cells displayed an 
enhanced response towards an angiotensin II challenge 
as shown in fig.1. The initial rate of accumulation of 
the two InsPs isomers and of InsP4 was augmented and 
remained at elevated levels compared to control cells 
ids 
45 60 180 
Time (s) 
Fig. 1 Time-course of angiotensin II-stimulated inositol polyphos- 
phate formation in control cells (0) and cells after 24 h pretreatment 
with 500 nM TPA (0). Results are expressed as lo3 x (radioactivity 
in inositol ~lyphosphat~/radioacti~ty of total water-soluble in- 
ositol) and are means of 5 experiments; the SE ranges from 3 to 10%. 
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Fig.2. Dose-dependency of 24 h TPA treatment on angiotensin II-stimulated InsPJ formation. Results are expressed as Vo of control, means -I 
SE for 5 experiments. 
for at least 3 min. TPA treatment also increased the 
basal values of Ins(1,4,5)P3. The stimulatory effect of 
TPA was dose-dependent as shown in fig.2. A 
minimum concentration of 30 nM of TPA was 
necessary to obtain a significant enhancement of 
angiotensin II-induced InsP3 generation. To exclude the 
possibility that TPA-induced enhancement of the 
angiotensin II effects after 24 h pretreatment was due to 
an increased density or affinity of receptors on 
mesangial cells the specific binding of (12’1) angiotensin 
II was determined. A linear Scatchard plot was obtain- 
ed suggesting one class of receptor sites. The maximal 
binding sites (4776 fmol/mg protein) and the apparent 
dissociation constant Kd (0.267 nM) were calculated. 
There was no significant difference in either the number 
of binding sites or their affinities for angiotensin II bet- 
ween control cells and cells treated with TPA (1 PM) for 
24 h. Fig.3 shows the fluorescence response to angioten- 
sin II (100 nM) of mesangial cells loaded with fluo-3. 
The (Ca2’)i in unstimulated cells was calculated to be 
165 k 26 nM, and angiotensin II increased this value by 
78+5 nM (mean&SD., n = 11 or 9, respectively) 
within IO-15 s. TPA treatment had no effect on basal 
(Ca2’)i (160 + 29 nM), but augmented the increase after 
stimulation with angiotensin II (97 +6 nM, mean + 
S.D., n= 12 or 13, respectively) and delayed the decay 
in (Ca2+)i observed thereafter (fig.3). A systematic 
statistical comparison between TPA-treated and con- 
trol cells demonstrated significant differences with 
respect o the elimination constant ~~1. The value of ~~1 
was calculated to be 9 t 2 s in control cells and 23 + 3 s 
in TPA-treated cells. Cells preincubated with TPA (1 
PM) for 24 h showed a significant increase in the percen- 
tage of contractions 3 and 5 min after addition of 
angiotensin II (10 nM) as compared to the respective 
Control MC 
t=BSOC 
~, / 
0 50 100 150 
Fig.3. [Ca’*)i responses to angiotensin II (100 nM) of control and 
TPA-treated (500 nM, 24 h) mesangial cells (MC) loaded with fluo-3. 
The x-axis corresponds to the time scale and the y-axis gives the 
relative intensity of the emitted fluorescence, which can be directly 
related to [Ca*‘]i. 
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Fig.4. (A), (B) Effect of 24 h TPA (1 CM) (hatched bars) or vehicle 
(open bars) treatment on angiotensin II-induced contractile activity of 
mesangial cells (MC). Data are expressed as the percentage of cells 
contracting 3 min (A), and 5 min (B) after the addition of angiotensin 
II (10 nM). Numbers in brackets indicate the number of cells 
evaluated. (C) Dose-dependency of TPA treatment (24 h) on 
angiotensin II-induced contractile activity 3 min (0) and 5 min (0) 
after hormone (10 nM) addition. 
control group (fig.4A,B). This effect of TPA was dose- 
dependent, as shown in fig.4C. 
4. DISCUSSION 
Angiotensin II-, vasopressin- and ATP-induced 
hydrolysis of phosphoinositides, with the subsequent 
formation of InsP3 and DG and the rise in cytosolic 
Ca’+, can be attenuated by short-term activation of 
protein kinase C in mesangial cells [ 1 l-131. These 
observations suggest that DG formation during hor- 
mone receptor activation may feedback to terminate 
phospholipase C-mediated InsP3 formation and 
calcium mobilization. Furthermore, such a modulation 
of signal transduction in calcium-mobilizing cells by 
protein kinase C has been proposed to be involved in 
angiotensin II-induced homologous desensitization in 
mesangial cells [5]. Inhibitors of protein kinase C, such 
as H-7, sphingosine and cytotoxin I, augmented 
angiotensin II-stimulated InsP3 formation [5], thus sug- 
gesting that blockage of protein kinase C results in an 
increased responsiveness of the inositol lipid signalling 
pathway to hormone stimulation. This study therefore 
was aimed to elucidate the angiotensin II responses in 
mesangial cells after protein kinase C down-regulation. 
We report that loss of protein kinase C resulted in a 
potentiation of angiotensin II-stimulated InsP3 forma- 
tion and Ca2+ mobilization. Enhanced phosphoino- 
sitide hydrolysis after long-term TPA treatment was 
recently reported for ATP-stimulated mesangial cells 
[ 131. Furthermore, down-regulation of protein kinase C 
in mesangial cells caused the calcium response to 
angiotensin II to increase in magnitude and to become 
much more persistent, in a way similar to what has been 
reported for A431 cells and vascular smooth muscle 
cells in response to epidermal growth factor, vaso- 
pressin or angiotensin II, respectively [22-251. Little is 
known about the precise molecular mechanism respon- 
sible for the negative feedback inhibition exerted by 
protein kinase C. The enhanced responsiveness to 
angiotensin II in protein kinase C down-regulated 
mesangial cells is not accompanied by an alteration in 
either the number of cellular receptors for angiotensin 
II or in their affinity. It appears that protein kinase C 
alters angiotensin II-induced generation of InsP3 by in- 
hibiting the signal transmission via the coupling G- 
protein. It has been reported that short-term pretreat- 
ment of washed membranes from glomerular mesangial 
cells [25] with TPA does not affect GTPyS-induced 
InsP3 formation. However, TPA pretreatment strongly 
decreases the synergistic effect of angiotension II on 
GTPyS-induced InsPa accumulation, thus suggesting 
that the coupling between the receptor and the G- 
protein might have been impaired. There may also be 
alternative target sites for protein kinase C. The marked 
prolongation of the Ca2+ elevation in protein kinase C 
down-regulated cells underscores the probable action of 
the kinase in modulating several key-steps in the signal- 
ling pathway from the angiotensin II receptor to cell 
contraction. This may include modulation of Ca2+ 
homeostatic mechanisms uch as the activation of the 
plasma membrane or endoplasmic reticulum 
Ca2+-ATPase [26,27] or inhibition of agonist-stimu- 
lated Ca2+ influx [28]. Further studies will be necessary 
to elucidate whether such a mode of action of protein 
kinase C also applies for mesangial cells. The effect of 
protein kinase C down-regulation in potentiating the 
contractile response of mesangial cells to a challenge 
with angiotensin II was unexpected. There is good 
evidence that protein kinase C contributes to the tonic 
phase of smooth muscle contraction [29] and it has also 
been demonstrated that TPA causes a slow contraction 
of mesangial cells [12]. However, our results show that 
(Ca2+)i is the major determinant of angiotensin II- 
induced contraction. The contribution of protein kinase 
C is an inhibitory one, leading to a rapid desensitization 
of the angiotensin II-stimulated signalling pathways. 
This might also explain why angiotensin II fails to pro- 
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duce a sustained contraction of mesangial cells. 
However, we cannot exclude the possibility that the 
small amount of residual protein kinase C activity re- 
maining in the cells following down-regulation might be 
responsible for cell contraction. It is well documented 
that several subspecies of protein kinase C exist [30] 
with different susceptibilities for TPA-induced down- 
regulation [31]. Further studies will be necessary to 
characterize the different species of protein kinase C 
present in mesangial cells and to appoint them to 
specific cellular functions. 
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